MDxHealth S.A. (MDXH)
MDXH Stock Price Chart
Explore MDxHealth S.A. interactive price chart. Choose custom timeframes to analyze MDXH price movements and trends.
MDXH Company Profile
Discover essential business fundamentals and corporate details for MDxHealth S.A. (MDXH) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
4 Nov 2021
Employees
312.00
Website
https://mdxhealth.comCEO
Michael K. McGarrity
Description
MDxHealth SA is a commercial-stage precision diagnostics firm delivering specialized urologic solutions across the globe. Its international footprint includes the United States, various European nations such as the Netherlands, Belgium, Spain, Poland, Italy, and the wider European Union. The company's innovative genomic testing portfolio for prostate cancer comprises SelectMDx, a non-invasive urine test, and ConfirmMDx, an epigenetic diagnostic tool. These advanced offerings enable medical professionals to precisely identify clinically significant prostate cancer, thereby minimizing reliance on invasive procedures and their associated risks. Established in 2003, with its headquarters in Herstal, Belgium, the entity was formerly known as OncoMethylome Sciences SA until its renaming to MDxHealth SA in October 2010.
MDXH Financial Timeline
Browse a chronological timeline of MDxHealth S.A. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 Aug 2026
EPS estimate is -$0.19, while revenue estimate is $26.14m.
Earnings released on 13 May 2026
EPS came in at -$0.19 falling short of the estimated -$0.14 by -31.35%, while revenue for the quarter reached $23.90m , missing expectations by -22.64%.
Earnings released on 13 May 2026
EPS came in at -$0.19 falling short of the estimated -$0.13 by -46.15%, while revenue for the quarter reached $29.55m , missing expectations by -2.67%.
Earnings released on 12 Nov 2025
EPS came in at -$0.16 falling short of the estimated -$0.11 by -49.73%, while revenue for the quarter reached $27.43m , missing expectations by -2.47%.
Earnings released on 12 Nov 2025
EPS came in at -$0.16 falling short of the estimated -$0.12 by -33.33%, while revenue for the quarter reached $53.21m , beating expectations by +103.24%.
Earnings released on 14 May 2025
EPS came in at -$0.19 falling short of the estimated -$0.13 by -46.15%, while revenue for the quarter reached $24.74m , beating expectations by +6.11%.
Earnings released on 14 May 2025
EPS came in at -$0.19 falling short of the estimated -$0.13 by -46.15%, while revenue for the quarter reached $24.29m , beating expectations by +1.71%.
Earnings released on 6 Nov 2024
EPS came in at -$0.40 falling short of the estimated -$0.27 by -48.21%, while revenue for the quarter reached $23.32m , beating expectations by +8.39%.
Earnings released on 21 Aug 2024
EPS came in at -$0.31 falling short of the estimated -$0.26 by -19.23%, while revenue for the quarter reached $41.99m , beating expectations by +97.73%.
Earnings released on 1 May 2024
EPS came in at -$0.31 falling short of the estimated -$0.30 by -3.60%, while revenue for the quarter reached $19.83m , beating expectations by +9.42%.
Earnings released on 1 May 2024
EPS came in at -$0.31 falling short of the estimated -$0.30 by -3.33%, while revenue for the quarter reached $19.40m , beating expectations by +4.52%.
Stock split effective on 14 Nov 2023
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 8 Nov 2023
EPS came in at -$0.40 falling short of the estimated -$0.31 by -29.03%, while revenue for the quarter reached $19.35m , beating expectations by +6.25%.
Earnings released on 15 May 2023
EPS came in at -$0.05 surpassing the estimated -$0.40 by +87.50%, while revenue for the quarter reached $14.70m , beating expectations by +8.42%.
Earnings released on 27 Oct 2022
EPS came in at -$0.05 surpassing the estimated -$0.55 by +90.91%, while revenue for the quarter reached $13.01m .
Earnings released on 25 Aug 2022
EPS came in at -$0.70 falling short of the estimated -$0.55 by -27.27%, while revenue for the quarter reached $13.01m .
Earnings released on 27 Apr 2022
EPS came in at -$0.05 surpassing the estimated -$0.55 by +90.91%, while revenue for the quarter reached $6.00m , missing expectations by -48.50%.
Earnings released on 2 Mar 2022
EPS came in at -$1.17 falling short of the estimated -$0.47 by -148.94%, while revenue for the quarter reached $6.00m .
Earnings released on 26 Aug 2021
Earnings released on 26 Aug 2021
EPS came in at -$1.20 surpassing the estimated -$1.30 by +7.69%, while revenue for the quarter reached $10.73m , missing expectations by -10.54%.
MDXH Stock Performance
Access detailed MDXH performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
